We are live on ! Find out more
RVMD icon

Revolution Medicines
RVMD

130 hedge funds and large institutions have $2.23B invested in Revolution Medicines in 2021 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 64 increasing their positions, 19 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

237% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 19

16% more call options, than puts

Call options by funds: $1.51M | Put options by funds: $1.3M

11% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 18

5.25% more ownership

Funds ownership: 90.57% → 95.81% (+5.2%)

2% more funds holding

Funds holding: 128 → 130 (+2)

20% less funds holding in top 10

Funds holding in top 10: 10 → 8 (-2)

27% less capital invested

Capital invested by funds: $3.05B → $2.23B (-$816M)

Holders
130
Holders Change
+2
Holders Change %
+1.56%
% of All Funds
2.26%
Holding in Top 10
8
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-20%
% of All Funds
0.14%
New
20
Increased
64
Reduced
19
Closed
18
Calls
$1.51M
Puts
$1.3M
Net Calls
+$213K
Net Calls Change
-$8.98M

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$57.9M
2
BlackRock
BlackRock
New York
+$34.5M
3
FCM
Farallon Capital Management
California
+$31.1M
4
CAM
Cormorant Asset Management
Massachusetts
+$28.4M
5
BG
Bellevue Group
Switzerland
+$27.5M

Top Sellers

Rank Fund Capital Flow
1
TGI
TRV GP II
Massachusetts
-$87.6M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$45.3M
3
Citadel Advisors
Citadel Advisors
Florida
-$32.1M
4
Victory Capital Management
Victory Capital Management
Texas
-$26.1M
5
BI
BVF Inc
California
-$16M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$16.7M +$12.8M +367,073 +230%
Bessemer Group
27
Bessemer Group
New Jersey
$13.9M – – –
Blackstone Inc
28
Blackstone Inc
New York
$13.2M +$14.5M +416,629 New
CS
29
Candriam SCA
Luxembourg
$12.5M +$13.8M +394,060 +3,940,600%
N
30
Nuveen
North Carolina
$11.7M +$5.68M +162,602 +78%
Charles Schwab
31
Charles Schwab
California
$11.3M +$1.4M +40,136 +13%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$7.37M +$3.15M +90,332 +64%
BBA
33
Baker Bros. Advisors
New York
$7.05M – – –
DCM
34
DAFNA Capital Management
California
$6.66M +$2.04M +58,500 +39%
Citadel Advisors
35
Citadel Advisors
Florida
$6.28M -$32.1M -919,431 -82%
Point72 Asset Management
36
Point72 Asset Management
Connecticut
$6.11M +$6.72M +192,600 New
Squarepoint
37
Squarepoint
New York
$4.63M +$5.09M +145,886 New
OCA
38
Octagon Capital Advisors
New York
$4M – – –
SCM
39
Soleus Capital Management
Connecticut
$3.99M +$2.39M +68,500 +120%
Citigroup
40
Citigroup
New York
$3.88M +$1.09M +31,314 +34%
Two Sigma Investments
41
Two Sigma Investments
New York
$3.87M +$3.53M +101,274 +493%
Deutsche Bank
42
Deutsche Bank
Germany
$3.46M +$1.02M +29,273 +37%
JMPWA
43
JP Morgan Private Wealth Advisors
California
$3.29M – – –
Swiss National Bank
44
Swiss National Bank
Switzerland
$3.28M +$2.02M +57,900 +127%
Norges Bank
45
Norges Bank
Norway
$2.75M -$2.87M -82,168 -49%
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$2.6M +$608K +17,428 +27%
RhumbLine Advisers
47
RhumbLine Advisers
Massachusetts
$2.48M +$1.13M +32,407 +71%
State of Wisconsin Investment Board
48
State of Wisconsin Investment Board
Wisconsin
$2.44M +$674K +19,300 +34%
Rafferty Asset Management
49
Rafferty Asset Management
New York
$2.42M +$212K +6,074 +9%
CSS
50
Cubist Systematic Strategies
Connecticut
$2.42M +$1.48M +42,415 +126%
1
2
3 4 5

RVMD Hedge Fund Activity: Q2 2021 in Review

130 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Revolution Medicines (RVMD) for Q2 2021, worth a combined $2.23B — down 27% from $3.05B a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new RVMD positions and 18 closed out — a net gain of 2 holders — while 64 added to existing stakes and 19 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $57.9M. The largest seller was TRV GP II, exiting entirely with an estimated $87.6M sold.

  • 130 institutional investors held Revolution Medicines (RVMD) as of Q2 2021, up from 128 in Q1 2021.
  • Funds reported $2.23B of Revolution Medicines stock for Q2 2021, down 27% quarter-over-quarter.
  • 20 funds opened new Revolution Medicines positions in Q2 2021 and 18 closed out, a net change of +2 holders.
  • The largest Revolution Medicines buyer in Q2 2021 was Wellington Management Group, an estimated $57.9M added.
  • The largest Revolution Medicines seller in Q2 2021 was TRV GP II, an estimated $87.6M sold.

Based on aggregated 13F filings for Q2 2021.